Cancer · 1991 · 55 citations · 19 references
MedicineOncologyPharmacotherapyChemotherapyGastrointestinal OncologyMedical OncologyChemotherapy Drug AdministrationColorectal CancerCombination ChemotherapyMetastatic Cancer ManagementMetastatic Disease Management5-Fluorouracil TreatmentChemotherapy Dose IntensityChemotherapy Response Assessment
One hundred eighty-four patients with advanced measurable colorectal cancer not previously treated with chemotherapy were entered into a prospective randomized clinical trial by the Mid-Atlantic Oncology Program (MAOP) to assess the value of weekly cisplatin (20 mg/m2) when added to a protracted schedule of 5-fluorouracil (5-FU) infusion (PIF) at 300 mg/m2/d for 10 weeks of every 12 weeks. The liver was the primary indicator lesion in approximately 75% of the study group. All tumor measurements required radiographic confirmation. The response rate in the PIF alone arm was 35% (29 of 83; 95% confidence interval [CI], 25% to 46%) compared with 33% (28 of 85; 95% CI, 23% to 44%) for the arm in which weekly cisplatin was added to PIF. The median survival times were 11.8 and 11.2 months in the two groups. Weekly cisplatin does not appear to add to the effectiveness of PIF in colorectal carcinoma.
19
Statistical Methods in Medical Research.
P. Armitage · Biometrics · 1972 · 4.1K citations
J J Lokich, James D. Ahlgren, John J. Gullo et al. · Journal of Clinical Oncology · 1989 · 772 citations
Medicine, Oncology, Pharmacology +15
Statistical Methods for Survival Data Analysis
Gary L. Tietjen · Journal of Quality Technology · 1981 · 748 citations